Chilton Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-510
Closed -$3.66K 717
2025
Q4
$3.66K Hold
510
﹤0.01% 518
2025
Q3
$5.45K Hold
510
﹤0.01% 516
2025
Q2
$4.94K Hold
510
﹤0.01% 489
2025
Q1
$7.59K Hold
510
﹤0.01% 472
2024
Q4
$7.61K Sell
510
-35
-6% -$570 ﹤0.01% 471
2024
Q3
$10.4K Sell
545
-50
-8% -$1.04K ﹤0.01% 477
2024
Q2
$12.3K Buy
595
+38
+7% +$755 ﹤0.01% 479
2024
Q1
$10.5K Buy
557
+12
+2% +$206 ﹤0.01% 472
2023
Q4
$7.86K Sell
545
-22
-4% -$299 ﹤0.01% 484
2023
Q3
$9.84K Hold
567
﹤0.01% 430
2023
Q2
$11.8K Sell
567
-6
-1% -$130 ﹤0.01% 441
2023
Q1
$13.5K Buy
+573
New +$15.4K ﹤0.01% 438
2022
Q3
Sell
-2,263
Closed -$76K 492
2022
Q2
$76K Buy
+2,263
New +$79.3K ﹤0.01% 291
2022
Q1
Sell
-2,666
Closed -$81K 489
2021
Q4
$81K Buy
+2,666
New +$86.8K ﹤0.01% 290

Other funds holding OGN

Chilton Capital Management's OGN Position: Q1 2026 in Review

Chilton Capital Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 510 shares — an estimated $3.66K sold.

Chilton Capital Management first reported a position in OGN in Q4 2021 and held it in 14 quarters. The position peaked at $81K in Q4 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Chilton Capital Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Chilton Capital Management sold 510 Organon & Co shares in Q1 2026, an estimated $3.66K.
  • Chilton Capital Management first reported a position in Organon & Co in Q4 2021 and held it in 14 quarters.
  • Chilton Capital Management's Organon & Co position peaked at $81K in Q4 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Chilton Capital Management's 13F filing for Q1 2026, filed 11 May 2026.